Kuros Biosciences Ag Stock Analysis

Kuros Pink Sheet Analysis Notes

About 35.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.79. Some equities with similar Price to Book (P/B) outperform the market in the long run. Kuros Biosciences recorded a loss per share of 0.24. The entity had not issued any dividends in recent years. The firm had 1:100 split on the 23rd of June 2016. Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. KUROS BIOSCIENCES operates under Biotechnology classification in the United States and is traded on PNK Exchange. It employs 58 people.The quote for Kuros Biosciences AG is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Kuros Biosciences AG please contact BSc BS at 41 44 733 4747 or go to https://www.kuros.ch.

Kuros Biosciences Investment Alerts

Kuros Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 70.16 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kuros Biosciences's market, we take the total number of its shares issued and multiply it by Kuros Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Kuros Profitablity

The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64.

Technical Drivers

As of the 24th of January, Kuros Biosciences secures the Standard Deviation of 5.65, mean deviation of 2.87, and Risk Adjusted Performance of (0.01). Kuros Biosciences AG technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kuros Biosciences information ratio and potential upside to decide if Kuros Biosciences AG is priced some-what accurately, providing market reflects its recent price of 21.4 per share. Given that Kuros Biosciences has information ratio of (0.03), we recommend you to check Kuros Biosciences's last-minute market performance to make sure the company can sustain itself at a future point.

Kuros Biosciences Price Movement Analysis

Kuros Biosciences Outstanding Bonds

Kuros Biosciences Predictive Daily Indicators

Kuros Biosciences Forecast Models

Kuros Biosciences' time-series forecasting models are one of many Kuros Biosciences' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kuros Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Kuros Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kuros shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Kuros Biosciences. By using and applying Kuros Pink Sheet analysis, traders can create a robust methodology for identifying Kuros entry and exit points for their positions.

When running Kuros Biosciences' price analysis, check to measure Kuros Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kuros Biosciences is operating at the current time. Most of Kuros Biosciences' value examination focuses on studying past and present price action to predict the probability of Kuros Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kuros Biosciences' price. Additionally, you may evaluate how the addition of Kuros Biosciences to your portfolios can decrease your overall portfolio volatility.